Comments on: Xtent, medical device company priced IPO at $16, trades at $17 http://deals.venturebeat.com/2007/02/01/xtent-medical-device-company-priced-ipo-at-16-trades-at-17/ News About Tech, Money and Innovation Sun, 22 Nov 2009 19:46:42 +0000 http://wordpress.org/?v=2.8.5 hourly 1 By: Nwe Nwe Oo http://deals.venturebeat.com/2007/02/01/xtent-medical-device-company-priced-ipo-at-16-trades-at-17/comment-page-1/#comment-800998 Nwe Nwe Oo Mon, 31 Mar 2008 21:18:17 +0000 http://www.venturebeat.com/wire/2007/02/01/xtent-medical-device-company-priced-ipo-at-16-trades-at-17/#comment-800998 Hi! Sar, I want to apply for Assembly (Production Builder). Please contact me. Hi! Sar,

I want to apply for Assembly (Production Builder).

Please contact me.

]]> By: VentureBeat » The storm over stents hits venture firms, as Devax yanks $85M IPO filing http://deals.venturebeat.com/2007/02/01/xtent-medical-device-company-priced-ipo-at-16-trades-at-17/comment-page-1/#comment-679758 VentureBeat » The storm over stents hits venture firms, as Devax yanks $85M IPO filing Fri, 14 Dec 2007 22:56:20 +0000 http://www.venturebeat.com/wire/2007/02/01/xtent-medical-device-company-priced-ipo-at-16-trades-at-17/#comment-679758 [...] in an IPO, while in July CardioMind pulled in $33 million in a third venture round (our coverage here and here). Other stent-related innovations, such as “bioresorbable” stents that [...] [...] in an IPO, while in July CardioMind pulled in $33 million in a third venture round (our coverage here and here). Other stent-related innovations, such as “bioresorbable” stents that [...]

]]> By: VentureBeat » Stent maker CardioMind raises $33M http://deals.venturebeat.com/2007/02/01/xtent-medical-device-company-priced-ipo-at-16-trades-at-17/comment-page-1/#comment-401630 VentureBeat » Stent maker CardioMind raises $33M Fri, 10 Aug 2007 23:50:21 +0000 http://www.venturebeat.com/wire/2007/02/01/xtent-medical-device-company-priced-ipo-at-16-trades-at-17/#comment-401630 [...] have continued to get a warm welcome from investors. Menlo Park, Calif.-based Xtent, for instance, raised $76 million in a February IPO. In May, Devax, a Lake Forest, Calif., stent developer, filed to raise up to $85 million in an [...] [...] have continued to get a warm welcome from investors. Menlo Park, Calif.-based Xtent, for instance, raised $76 million in a February IPO. In May, Devax, a Lake Forest, Calif., stent developer, filed to raise up to $85 million in an [...]

]]>